CKD-aP Treatment Tool Kit
Leonie Kraft, MD
Emilio Sanchez, MD, PhD
Elevating CKD-aP Care: New Frontier
James Burton, DM, FRCP
Lucio Manenti, MD, PhD
Is CKD-aP Hiding in Your Dialysis Center?
The Critical Interplay: CKD, HF, and Hyperkalemia
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Future Directions in Managing Hyperkalemia in CKD and HF
Javed Butler, MD, MPH, MBA
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Potassium Binders in Practice: Clinical Trial Evidence
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
Don't Miss It! Rapid & Accurate AAV Diagnosis
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
Optimizing AAV Outcomes: Maintenance Therapies
Bernhard Hellmich, MD
Managing Patients With AAV in the Rheumatology Clinic
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.